(Q35071439)

6 August 2017

1 reference

title

Fibroblast growth factors and their receptors in urological cancers: basic research and clinical implications (English)

1 reference

6 August 2017

Cronauer MV

1

1 reference

6 August 2017

Schulz WA

2

1 reference

6 August 2017

Seifert HH

3

1 reference

6 August 2017

Ackermann R

4

1 reference

6 August 2017

Burchardt M

5

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

6 August 2017

1 reference

6 August 2017

43

1 reference

6 August 2017

309-319

1 reference

6 August 2017

3

1 reference

Increased immunodetection of acidic fibroblast growth factor in bladder cancer, detectable in urine

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Immunohistochemical detection of acidic fibroblast growth factor in bladder transitional cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Basic fibroblast growth factor levels in cancer cells and in sera of patients suffering from proliferative disorders of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Expression of basic fibroblast growth factor in primary human renal tumors: correlation with poor survival

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Predominant expression of fibroblast growth factor (FGF) 8, FGF4, and FGF receptor 1 in nonseminomatous and highly proliferative components of testicular germ cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Heparin binding growth factors and the control of teratoma cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Heparin protects basic and acidic FGF from inactivation

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Fibroblast growth factors, their receptors and signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Identification of a novel FGF, FGF-21, preferentially expressed in the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Identification of a novel fibroblast growth factor, FGF-22, preferentially expressed in the inner root sheath of the hair follicle

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Receptor specificity of the fibroblast growth factor family

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Detection of high levels of heparin binding growth factor-1 (acidic fibroblast growth factor) in inflammatory arthritic joints

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

"Pure" human hematopoietic progenitors: permissive action of basic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Basic fibroblast growth factor regulates matrix metalloproteinases production and in vitro invasiveness in human bladder cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

FGFs, heparan sulfate and FGFRs: complex interactions essential for development

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Enhancement of fibroblast growth factor (FGF) activity by an FGF-binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Localisation of a fibroblast growth factor and its effect alone and with hydrocortisone on 3T3 cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Fibroblast growth factor in the extracellular matrix of dystrophic (mdx) mouse muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Heparin potentiates the action of acidic fibroblast growth factor by prolonging its biological half-life

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Alternative initiation of translation determines cytoplasmic or nuclear localization of basic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Fibroblast growth factor-2 (FGF-2) in the nucleus: translocation process and targets

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Growth factors are released by mechanically wounded endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Extracellular sequestration and release of fibroblast growth factor: a regulatory mechanism?

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Recovery of mitogenic activity of a growth factor mutant with a nuclear translocation sequence.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Angiogenic activity of the recombinant hst-1 protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Vascular endothelial growth factor and fibroblast growth factor 5 are colocalized in vascular and avascular epiretinal membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

FGF-2 regulation of neurogenesis in adult hippocampus after brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Fibroblast growth factors induce additional limb development from the flank of chick embryos

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Roles for FGF8 in the induction, initiation, and maintenance of chick limb development

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Intravenous basic fibroblast growth factor (bFGF) decreases DNA fragmentation and prevents downregulation of Bcl-2 expression in the ischemic brain following middle cerebral artery occlusion in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

bcl-2 gene prevents apoptosis of basic fibroblast growth factor-deprived murine aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Induction of Mdm2 and enhancement of cell survival by bFGF.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Fibroblast growth factors: an epigenetic mechanism of broad spectrum resistance to anticancer drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Heparanase as mediator of angiogenesis: mode of action

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

An FGF-binding protein (FGF-BP) exerts its biological function by parallel paracrine stimulation of tumor cell and endothelial cell proliferation through FGF-2 release

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Ribozyme-targeting of a secreted FGF-binding protein (FGF-BP) inhibits proliferation of prostate cancer cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Fibroblast growth factor-binding protein expression changes with disease progression in clinical and experimental human squamous epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Up-regulation of a fibroblast growth factor binding protein in children with renal diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

T lymphocytes synthesize and export heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor, mitogens for vascular cells and fibroblasts: differential production and release by CD4+ and CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

A reliable system for the culture of human prostatic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

FGF8 over-expression in prostate cancer is associated with decreased patient survival and persists in androgen independent disease

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

aFGF immunoreactivity in prostate cancer and its co-localization with bFGF and FGF8

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Fibroblast growth factor-10. A second candidate stromal to epithelial cell andromedin in prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Serum keratinocyte growth factor measurement in patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Basic fibroblast growth factor synthesis by human peritoneal mesothelial cells: induction by interleukin-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Interleukin-1alpha is a paracrine inducer of FGF7, a key epithelial growth factor in benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Cloning and characterization of an androgen-induced growth factor essential for the androgen-dependent growth of mouse mammary carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Increased expression of FGF-8 isoforms and FGF receptors in human premalignant prostatic intraepithelial neoplasia lesions and prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Regulation of FGF8 expression by the androgen receptor in human prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Serum basic fibroblast growth factor in men with and without prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Androgen receptor protein is down-regulated by basic fibroblast growth factor in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Role of fibroblast growth factor receptor signaling in prostate cancer cell survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

FGF9 is an autocrine and paracrine prostatic growth factor expressed by prostatic stromal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Expression of metalloproteinase genes in human prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Promatrilysin expression is induced by fibroblast growth factors in the prostatic carcinoma cell line LNCaP but not in normal primary prostate epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Aberrant expression of fibroblast growth factor receptor-1 in prostate epithelial cells allows induction of promatrilysin expression by fibroblast growth factors

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

FGF-2 and FGF-1 expressed in rat bladder carcinoma cells have similar angiogenic potential but different tumorigenic properties in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Urinary basic fibroblast growth factor in patients with bladder cancer and benign prostatic hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Expression of basic fibroblast growth factor and its receptor in an invasive bladder carcinoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Expression and functions of EGF, FGF and TGFbeta-growth-factor family members and their receptors in invasive human transitional-cell-carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Decreased expression of keratinocyte growth factor receptor in a subset of human transitional cell bladder carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Frequency of fibroblast growth factor receptor 3 mutations in sporadic tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Basic fibroblast growth factor as a candidate tumor marker for renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Messenger ribonucleic acids for fibroblast growth factors and their receptor in bladder and renal cell carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Expression of the HST1 oncogene in human germ cell tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Modulation of fibroblast growth factor receptor expression and signalling during retinoic acid-induced differentiation of Tera-2 teratocarcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Expression of basic fibroblast growth factor (FGF-2)-associated with tumour proliferation in human pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Thalidomide is an inhibitor of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Continuous low dose Thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Suramin: a novel growth factor antagonist with activity in hormone-refractory metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Suramin, an active drug for prostate cancer: interim observations in a phase I trial

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Suramin inhibits bFGF-induced endothelial cell proliferation and angiogenesis in the chick chorioallantoic membrane.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900005-8

7 January 2021

10.1016/S0302-2838(03)00005-8

Identifiers

DOI

1 reference

6 August 2017

1 reference